The Canadian Association for Neuroscience was proud to host its annual CAN Parliament Hill Day in Ottawa on November 5, 2024.
It was a full day of meetings with elected officials and representatives of the main federal funding agencies to discuss how to better support scientific research in Canada.
Continue reading
Dr. Sheena Josselyn
Scientists use a peptide to strengthen connections between brain cells and restore memory in a pre-clinical model.
Research led at The Hospital for Sick Children (SickKids) is illuminating the mechanism underlying memory, which could result in future therapeutic targets for conditions such as Alzheimer’s disease and dementia.
Alzheimer’s disease is a condition that causes memory loss, characterized by the accumulation of a protein, called A-beta, in the brain that damages neurons and their connections.
Published in Nature Neuroscience, Drs. Paul Frankland and Sheena Josselyn, Senior Scientists in the Neurosciences & Mental Health program, used a peptide to block adverse effects of the accumulation of A-beta in pre-clinical models – a technique that showed promise in restoring memory.
Continue readingThe House of Commons Standing Committee on Finance invited Canadians to participate in its annual pre-budget consultations process. The committee will table a report on these consultations in the House of Commons with recommendations to be considered by the Deputy Prime Minister and Minister of Finance in the development of the 2025 federal budget.
Read CAN’s submission to these consultations here:
The Canadian Association for Neuroscience (CAN) and the Canadian Institutes of Health’s Institute of Neurosciences, Mental Health and Addiction (CIHR-INMHA) are proud to announce the winners of the 2023 Brain Star Awards.
The CIHR-INMHA Brain Star awards, administered by the Canadian Association for Neuroscience, are awarded to students and trainees who have published high impact discoveries in all fields and disciplines covered by CIHR’s Institute of Neurosciences, Mental Health and Addiction in the 2023 calendar year.
The top 3 Brain Star Award winners of the year have been invited to make a presentation at the CAN meeting in May.
The Canadian Association for Neuroscience is very proud to announce that Dr. Caroline Ménard from Université Laval is the winner of the 2024 CAN New Investigator Award. Her innovative research program is shedding light on the biological mechanisms underlying vulnerability and resilience to stress, with the help of state-of-the-art photonic technology and with the aim of developing pioneer strategies to treat or prevent depression.
Read our latest newsletter today!
Table of content:
Source of story: MS Canada website
Summary: Researchers find that a non-drug based treatment approach called acute intermittent hypoxia (AIH), which consists of short periods of reduced oxygen, reduces inflammation, protects nerve fibres, and promotes repair in mice with multiple sclerosis-like disease. While the findings of this study are promising, further research will need to assess whether this treatment has the same effect in people with MS.
Continue reading
